Market Place
Sourcing Support
ImmuPharma’s Lupus therapy adaptive trial to commence in second half
20 Jun 2023 //
CLINICAL TRIALS ARENA
ImmuPharma initiates phase 2/3 clinical trial for lupus treatment
19 Jun 2023 //
PHARMAFILE
ImmuPharma says it welcomes `helpful` FDA recommendations ahead of ph III study
30 Sep 2022 //
PROACTIVEINVESTORS
Immupharma PLC: Written Response received from the FDA
14 Sep 2022 //
INVESTIGATE
ImmuPharma raises GBP950,000 from broker option
11 Aug 2022 //
ISE
UPDATE on P140 (LUPUZOR™) clinical progress
13 Apr 2022 //
PRESS RELEASE
FDA approves the Lupzuor PK study
12 Aug 2021 //
PRESS RELEASE
ImmuPharma’s efforts in the fight against Covid-19 with Lupuzor™ and Ureka
14 May 2020 //
PRESS RELEASE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.